Martin Højgaard

548 total citations
22 papers, 196 citations indexed

About

Martin Højgaard is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Martin Højgaard has authored 22 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Martin Højgaard's work include Cancer Genomics and Diagnostics (7 papers), DNA Repair Mechanisms (6 papers) and Genetic factors in colorectal cancer (4 papers). Martin Højgaard is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), DNA Repair Mechanisms (6 papers) and Genetic factors in colorectal cancer (4 papers). Martin Højgaard collaborates with scholars based in Denmark, United Kingdom and United States. Martin Højgaard's co-authors include Jón Trærup Andersen, K. J. Mikines, Henrik E. Poulsen, Jens Lykkesfeldt, Niklas Rye Jørgensen, Trine Henriksen, Bo Zerahn, Bent Bruun Kristensen, Thomas W. Vogelsang and Andreas Kjær and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Martin Højgaard

18 papers receiving 188 citations

Peers

Martin Højgaard

PFM

ONCOL

SURGE

Michał Falco Poland

Zhentao Zhang China

Abbas Mosapour Iran

Edmone Dewaeles France

Shanshan Xue China

Encheng Zhou China

Yen-Li Lo Taiwan

Domingos Araújo Portugal

Michael Schiff United States

Michał Falco Poland

Martin Højgaard

84 ×1.0

19 ×0.4

PFM

28 ×0.7

48 ×1.3

ONCOL

28 ×1.1

SURGE

Citations per year, relative to Martin Højgaard Martin Højgaard (= 1×) peers Michał Falco

Countries citing papers authored by Martin Højgaard

Since Specialization

Citations

This map shows the geographic impact of Martin Højgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Højgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Højgaard more than expected).

Fields of papers citing papers by Martin Højgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Højgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Højgaard. The network helps show where Martin Højgaard may publish in the future.

Co-authorship network of co-authors of Martin Højgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Højgaard. A scholar is included among the top collaborators of Martin Højgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Højgaard. Martin Højgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yde, Christina W., A. Schmidt, Martin Højgaard, et al.. (2026). Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform. Cells. 15(3). 259–259.

Højgaard, Martin, Iben Spanggaard, Ulrik Lassen, et al.. (2025). Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting. Annals of Oncology. 36(9). 1078–1087. 2 indexed citations

Wang, Juanjuan, Annelaura Bach Nielsen, Filip Mundt, et al.. (2025). Integrating deep proteomics into precision oncology for multi-omics characterization of metastatic cancer.. Journal of Clinical Oncology. 43(16_suppl).

Fontana, Elisa, Ezra Y. Rosen, Elizabeth K. Lee, et al.. (2024). Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study). JNCI Journal of the National Cancer Institute. 116(9). 1439–1449. 7 indexed citations

Urup, Thomas, Hans Skovgaard Poulsen, Kirsten Grunnet, et al.. (2024). Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023. Neuro-Oncology Practice. 12(1). 34–44. 3 indexed citations

Riley, Caroline Hasselbalch, Søren Lykke Petersen, Iben Spanggaard, et al.. (2024). Cytokine release syndrome caused by antineoplastic treatment with CAR-T and T-cell engaging therapies. Ugeskrift for Læger. 186(9). 1–9.

Poulsen, Tim Svenstrup, et al.. (2024). TMPRSS2:ERGGene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer. Anticancer Research. 44(10). 4203–4211. 2 indexed citations

Rosen, Ezra Y., Timothy A. Yap, Elizabeth K. Lee, et al.. (2023). Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib. Clinical Cancer Research. 30(4). 687–694. 4 indexed citations

Bertelsen, Birgitte, Karin Wadt, Iben Spanggaard, et al.. (2023). New pathogenic germline variants identified in mesothelioma. Lung Cancer. 179. 107172–107172. 3 indexed citations

10.

Højgaard, Martin, Kristoffer Staal Rohrberg, Iben Spanggaard, et al.. (2023). ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial. BMC Cancer. 23(1). 182–182. 11 indexed citations

11.

Pinato, David J., Ruth Plummer, Martin Gutierrez, et al.. (2022). 622 A phase 1 study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor, INCB099318, in patients with select advanced solid tumors. Regular and Young Investigator Award Abstracts. A654–A654. 3 indexed citations

12.

Yap, Timothy A., Ian M. Silverman, Elisa Fontana, et al.. (2022). Abstract CT030: Genomic and pathologic determinants of response to RP-3500, an ataxia telangiectasia and Rad3-related inhibitor (ATRi), in patients (pts) with DNA damage repair (DDR) loss-of-function (LOF) mutant tumors in the Phase 1/2 TRESR trial. Cancer Research. 82(12_Supplement). CT030–CT030. 8 indexed citations

13.

Spanggaard, Iben, Martin Højgaard, Christina W. Yde, et al.. (2022). Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact. Acta Oncologica. 61(12). 1499–1506.

14.

Rosen, Ezra Y., et al.. (2022). 5MO Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase. Annals of Oncology. 33. S3–S4. 3 indexed citations

15.

Rafaeva, Maria, Edward R. Horton, Chris D. Madsen, et al.. (2021). Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor. Advanced Healthcare Materials. 11(1). e2100684–e2100684. 16 indexed citations

16.

Yap, Timothy A., Elizabeth Lee, David R. Spigel, et al.. (2021). Abstract CC04-01: First-in-human biomarker-driven phase I TRESR trial of ataxia telangiectasia and Rad3-related inhibitor (ATRi) RP-3500 in patients (pts) with advanced solid tumors harboring synthetic lethal (SL) genomic alterations. Molecular Cancer Therapeutics. 20(12_Supplement). CC04–1. 4 indexed citations

17.

Højgaard, Martin, Jón Trærup Andersen, Niklas Rye Jørgensen, et al.. (2017). Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial. Translational Andrology and Urology. 6(3). 517–528. 42 indexed citations

18.

Højgaard, Martin, et al.. (2014). Elimination of Ascorbic Acid After High‐Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation. Basic & Clinical Pharmacology & Toxicology. 116(4). 343–348. 60 indexed citations

19.

Højgaard, Martin & K. J. Mikines. (2010). Ureteral injuries during photoselective vaporization of the prostate. Scandinavian Journal of Urology and Nephrology. 44(4). 265–268. 3 indexed citations

20.

Vogelsang, Thomas W., Chie Yoshiga, Martin Højgaard, et al.. (2006). The plasma atrial natriuretic peptide response to arm and leg exercise in humans: effect of posture. Experimental Physiology. 91(4). 765–771. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact